EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway

Yuan Cao, Zhiqiang Peng, Tenghua Yu, Hanzhi Dong

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 13497-13512

DOI: 10.1007/s00210-026-05146-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 27.03.2026. Verfasst von Yuan Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, N…. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Y-Box-Binding Protein 1, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelTriple Negative Breast NeoplasmsY-Box-Binding Protein 1Drug Resistance, NeoplasmWnt Signaling PathwayAntineoplastic Agents, PhytogenicHumansFemaleAnimalsCell ProliferationApoptosisCell Line, TumorMice, NudeDisease ProgressionMice, Inbred BALB Cbeta CateninCell SurvivalXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Drug resistancePaclitaxelTNBCWnt/β-catenin pathwayYB-1

Substanzen

PaclitaxelY-Box-Binding Protein 1YBX1 protein, humanAntineoplastic Agents, Phytogenicbeta Catenin

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, Nanchang, 330000, China.
  • Department of Lymphohematology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, China.
  • Department of Breast Surgery, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, China.
  • Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Zheng Street, Donghu District, Nanchang, 330000, China. ndzhlyy1394@ncu.edu.cn.

Förderung

  • The National Nature Science Foundation of China

Zitieren

APA

Cao, Y., Peng, Z., Yu, T., & Dong, H. (2026). YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 13497-13512. https://doi.org/10.1007/s00210-026-05146-7

Vancouver

Cao Y, Peng Z, Yu T, Dong H. YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):13497-13512. doi:10.1007/s00210-026-05146-7

BibTeX
@article{Cao2026,
  author = {Cao, Yuan and Peng, Zhiqiang and Yu, Tenghua and Dong, Hanzhi},
  title = {YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {9},
  pages = {13497--13512},
  doi = {10.1007/s00210-026-05146-7}
}
Kostenlos starten →